UB824
ProductProgesterone Injection
Strength1ml:50mg
IndicationsAmenorrhea; Functional uterine bleeding; Luteal insufficiency; Threatened miscarriage; Habitual miscarriage; Premenstrual tension syndrome
TherapeuticsWomen's Health
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule
Exclusive Summary
- Features an innovative 1ml:50mg high-concentration formulation that delivers the standard daily dose for ART luteal support in a single vial, reducing injection volume by up to 80% and significantly minimizing injection site pain.
- Built on robust evidence and compliance, aligning perfectly with ESHRE 2020 guidelines while holding PIC/S GMP certification (with US FDA GMP inspection targeted for 2026), ensuring streamlined global market access.
- Offers massive commercial upside in the globally expanding $36 Billion ART market, backed by a striking 30-60% pricing advantage over US/EU equivalents that clearly guarantees high margins for overseas distributors.
Asset Materials
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →